Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 12.2B | 4.7B | 13.7B | 13.6B |
Cost of revenue | 2.5B | 828M | 1.8B | 1.8B |
Gross profit | 9.7B | 3.9B | 11.9B | 11.8B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 2.6B | 2.1B | 2.4B | 2.4B |
Operating income | 4.5B | -82M | 7.6B | 7.6B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 102M | 44M | 41M | 52M |
Other income expense | — | — | — | — |
Pretax income | 5.1B | 1.6B | 8.2B | 8.0B |
Tax provision | 999M | 313M | 1.4B | 1.4B |
Net income | 4.1B | 1.3B | 6.8B | 6.7B |
Basic EPS | — | 7.4 | 37.8 | 37.3 |
Diluted EPS | — | 7.4 | 37.8 | 37.3 |
Basic average shares | — | 179.0M | 179.1M | 179.1M |
Diluted average shares | — | 179.0M | 179.1M | 179.1M |
EBITDA | 6.1B | 2.2B | 8.7B | 8.5B |
Net income from continuing op. | — | — | — | — |
Minority interests | 6M | 6M | 8M | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |